Pharvaris NV (PHVS)
NASDAQ
| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-06-15 | Mr. Berndt Axel Edvard ModigCo-Founder, CEO & Executive Director | -2.29k | 71.17k | Automatic Disposition | 31.05 - 31.46 | 1.09M | -0.21% |
| 2026-06-12 | Dr. Peng LuPresident | -117.00 | 3.77k | Sale to Issuer | 32.20 | 65.63k | -0.18% |
| 2026-06-11 | Dr. Peng LuPresident | -109.00 | 3.43k | Sale to Issuer | 31.51 | 65.75k | -0.17% |
| 2026-06-04 | Ms. Anna NijdamHead of Strategic Finance & Principal Accounting Officer | -2.67k | 82.43k | 売り | 30.87 | 46.28k | -5.46% |
| 2026-05-15 | Dr. Robert GlassmanIndependent Non-Executive Director | -4.67k | 139.15k | 売り | 29.82 | 10.50k | -30.77% |
| 2026-05-15 | Dr. Robert GlassmanIndependent Non-Executive Director | -5.33k | 40.11k | Derivative Exercise and Sale | 22.31 - 29.83 | 10.50k | - |
| 2026-05-15 | Mr. Wim SouverijnsChief Commercial Officer | -10.00k | 299.16k | Automatic Disposition | 29.92 | 45.11k | -18.15% |
| 2026-05-11 | Dr. Peng LuPresident | -226.00 | 6.78k | Sale to Issuer | 29.95 - 30.09 | 65.86k | -0.34% |
| 2026-04-29 | Mr. Hans J. G. C. P. SchikanIndependent & Non-Executive Vice Chair | -32.90k | 996.54k | Automatic Disposition | 30.07 - 31.03 | 355.17k | -8.48% |
| 2026-04-29 | Dr. Anne A. LesageChief Early Development Officer | -22.90k | 692.14k | Automatic Disposition | 30.06 - 30.26 | 190.42k | -10.74% |
| 2026-04-29 | Dr. Anne A. LesageChief Early Development Officer | -25.40k | 603.77k | Derivative Exercise and Sale | 2.59 - 30.26 | 190.42k | - |
| 2026-04-29 | Dr. Peng LuPresident | -18.73k | 517.34k | Derivative Exercise and Sale | 2.59 - 30.24 | 66.08k | - |
| 2026-04-22 | Mr. Hans J. G. C. P. SchikanIndependent & Non-Executive Vice Chair | -7.10k | 213.38k | Automatic Disposition | 30.03 - 30.05 | 388.07k | -1.80% |
| 2026-04-22 | Dr. Anne A. LesageChief Early Development Officer | -7.10k | 213.36k | 売り | 30.03 - 30.05 | 178.10k | -3.83% |
| 2026-04-22 | Dr. Anne A. LesageChief Early Development Officer | -7.60k | 170.46k | Derivative Exercise and Sale | 2.59 - 30.05 | 178.10k | - |
| 2026-04-22 | Dr. Peng LuPresident | -7.10k | 195.01k | Derivative Exercise and Sale | 2.59 - 30.05 | 66.08k | - |
| 2026-04-16 | Dr. Peng LuPresident | -226.00 | 6.50k | Sale to Issuer | 28.78 | 66.08k | -0.34% |
| 2026-04-16 | Mr. Berndt Axel Edvard ModigCo-Founder, CEO & Executive Director | -2.29k | 65.56k | Automatic Disposition | 28.60 | 1.09M | -0.21% |
| 2026-04-11 | Ms. Anna NijdamHead of Strategic Finance & Principal Accounting Officer | -548.00 | 14.59k | Sale to Issuer | 26.63 | 48.94k | -1.11% |
| 2026-04-09 | Mr. Berndt Axel Edvard ModigCo-Founder, CEO & Executive Director | -23.33k | 647.28k | Automatic Disposition | 27.74 - 28.42 | 1.09M | -2.09% |
| 2026-04-06 | Ms. Anna NijdamHead of Strategic Finance & Principal Accounting Officer | -1.17k | 33.33k | Sale to Issuer | 28.56 | 49.49k | -2.30% |
| 2026-04-01 | Ms. Anna NijdamHead of Strategic Finance & Principal Accounting Officer | -1.16k | 32.88k | Sale to Issuer | 28.25 | 50.66k | -2.25% |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
すでにアカウントをお持ちですか? サインイン
アカウントをお持ちでないですか? 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。